The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study
Abstract
The frequency of antibiotic-associated diarrhoea (AAD) and Clostridium difficile-associated diarrhoea (CdAD) was prospectively determined in a population of 2462 patients recruited from five Swedish hospitals, including divisions for infectious diseases, orthopaedics, surgery, geriatrics, nephrology and internal medicine. AAD developed in 4.9% of the treated patients. Faecal samples were obtained from 69% of patients with AAD and 55.4% were positive for C. difficile cytotoxin B. The frequency of AAD varied from 1.8 to 6.9% at the participating centres (P < 0.001). The frequency of AAD also varied considerably between medical disciplines and wards within different hospitals and was highest in the nephrology and geriatric units (6.7 and 7.1%, respectively). There was no difference in frequency of AAD when analysed with respect to gender or age. Medical interventions (laxative treatment, endoscopy and abdominal surgery) or presence of one concomitant disease (diabetes, malignancy, chronic renal disease and inflammatory bowel disease) did not significantly affect the frequency of AAD, whereas patients suffering from two or more of these illnesses had significantly (P = 0.001) higher frequencies of AAD. Patients treated with antibiotics for 3 days had a significantly (P = 0.009) lower frequency of AAD than those treated for longer periods. Treatment with cephalosporins, clindamycin or broad-spectrum penicillins was associated with an increased risk of AAD. With specimens from one centre, 62.5% of tested patients with AAD and 33.8% of asymptomatic patients were positive for cytotoxin B. Although C. difficile cytotoxin B in stool samples was significantly associated with AAD (P = 0.003), the causal relationship with diarrhoea is not always evident.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Risk factors for Clostridium difficile infection
Bignardi, G. E. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90019-6 · Cited by 647
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., & Van Belle, G. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91613-2 · Cited by 573
Clabots, C. R., Johnson, S., Olson, M. M., Peterson, L. R., & Gerding, D. N. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.3.561 · Cited by 476
McFarland, L. V., Surawicz, C. M., & Stamm, W. E. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.3.678 · Cited by 378
Mechanisms and Management of Antibiotic‐Associated Diarrhea
Hogenauer, C., Hammer, H. F., Krejs, G. J., & Reisinger, E. C. (1998) · Clinical Infectious Diseases · doi:10.1086/514958 · Cited by 348
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K., & Cox, J. L. (1995) · PubMed · Cited by 338
Clostridium difficile Colonization and Diarrhea at a Tertiary Care Hospital
Samore, M. H., DeGirolami, P. C., Tlucko, A., Lichtenberg, D. A., Melvin, Z. A., & Karchmer, A. W. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.181 · Cited by 251
Aronsson, B., Mollby, R., & Nord, C. E. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.3.476 · Cited by 245
Financial burden of hospital-acquired Clostridium difficile infection
Wilcox, M. H., Cunniffe, J. G., Trundle, C., & Redpath, C. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90122-x · Cited by 244
Cited by
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Ben-Zeev Brik, R., Federici, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.047 · Cited by 1,184
Antibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197
Gavazzi, G., & Krause, K.-H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00437-1 · Cited by 990
The Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 826
Kampf, G., & Kramer, A. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.863-893.2004 · Cited by 763
BSAC standardized disc susceptibility testing method (version 7)
Andrews, J. M., & Testing, F. T. B. W. P. O. S. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn194 · Cited by 734
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 607
Narrative Review: The New Epidemic of Clostridium difficile–Associated Enteric Disease
Bartlett, J. G. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00008 · Cited by 599
Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577
Impact of Clostridium difficile on Inflammatory Bowel Disease
Issa, M., Vijayapal, A., Graham, M. B., Beaulieu, D. B., Otterson, M. F., Lundeen, S., Skaros, S., Weber, L. R., Komorowski, R. A., Knox, J. F., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.028 · Cited by 570
Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913554107 · Cited by 530
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Stevens, V., Dumyati, G., Fine, L. S., Fisher, S. G., & van Wijngaarden, E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir301 · Cited by 446
The Role of the Intestinal Tract as a Reservoir and Source for Transmission of Nosocomial Pathogens
Donskey, C. J. (2004) · Clinical Infectious Diseases · doi:10.1086/422002 · Cited by 424
Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics
Hensgens, M. P. M., Goorhuis, A., Dekkers, O. M., & Kuijper, E. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr508 · Cited by 399
Thirty Years of Lactobacillus rhamnosus GG: A Review
Capurso, L. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001170 · Cited by 381
Clostridium difficile–Associated Diarrhea: A Review
Mylonakis, E., Ryan, E. T., & Calderwood, S. B. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.4.525 · Cited by 339
Antibiotic-Associated Diarrhea: Epidemiology, Trends and Treatment
McFarland, L. V. (2008) · Future Microbiology · doi:10.2217/17460913.3.5.563 · Cited by 333
Infection control measures to limit the spread of Clostridium difficile
Vonberg, R.-P., Kuijper, E. J., Wilcox, M. H., Barbut, F., Tüll, P., Gastmeier, P., van den Broek, P. J., Colville, A., Coignard, B., Daha, T., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01992.x · Cited by 314
Kotowska, M., Albrecht, P., & Szajewska, H. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02356.x · Cited by 286
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Guo, Q., Goldenberg, J. Z., Humphrey, C., El Dib, R., & Johnston, B. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub5 · Cited by 275
“Reports in the general population indicate that the incidence of AAD ranges from 5 to 62%, occurring at any point from the initiation of therapy to two months after the end of treatment (McFarland 2008; LaRosa 2003; Wistrom 2001; McFarland 1998).”
BackgroundRecent advances in the understanding of antibiotic resistance in Clostridium difficile infection
Spigaglia, P. (2016) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115622891 · Cited by 254
Probiotic approach to prevent antibiotic resistance
Ouwehand, A. C., Forssten, S., Hibberd, A. A., Lyra, A., & Stahl, B. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1161232 · Cited by 216
“AAD is relatively common with a prevalence varying 5–35% depending on the type of antibiotic and length of treatment, age, concomitant diseases and hospitalization (20,21).”
BackgroundBlaabjerg, S., Artzi, D., & Aabenhus, R. (2017) · Antibiotics · doi:10.3390/antibiotics6040021 · Cited by 208
“In particular, aminopenicillins, cephalosporins, and clindamycin that act on anaerobes are associated with a high risk of AAD [2].”
BackgroundClayton, E. M., Rea, M. C., Shanahan, F., Quigley, E. M. M., Kiely, B., Hill, C., & Ross, R. P. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.4 · Cited by 202
Hagihara, M., Kuroki, Y., Ariyoshi, T., Higashi, S., Fukuda, K., Yamashita, R., Matsumoto, A., Mori, T., Mimura, K., Yamaguchi, N., et al. (2020) · iScience · doi:10.1016/j.isci.2019.100772 · Cited by 162
Cindoruk, M., Erkan, G., Karakan, T., Dursun, A., & Unal, S. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00516.x · Cited by 135
Managing antibiotic associated diarrhoea: Probiotics may help in prevention
Barbut, F., & Meynard, J. L. (2002) · BMJ · doi:10.1136/bmj.324.7350.1345 · Cited by 100
Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study
Ouwehand, A. C., DongLian, C., Weijian, X., Stewart, M., Ni, J., Stewart, T., & Miller, L. E. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.053 · Cited by 98
Neut, C., Mahieux, S., & Dubreuil, L. J. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.07.001 · Cited by 96
Horosheva, T. V., Vodyanoy, V., & Sorokulova, I. (2014) · JMM Case Reports · doi:10.1099/jmmcr.0.004036 · Cited by 57
“The route of antibiotic administration (oral or parenteral) does not affect the rate of AAD (Bartlett, 2002), and no difference has been found in frequency of AAD with respect to age and gender (Wistrom et al., 2001).”
BackgroundMa, Y., Yang, J. Y., Peng, X., Xiao, K. Y., Xu, Q., & Wang, C. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12839 · Cited by 44
The immune interactions of gut glycans and microbiota in health and disease
(2024) · doi:10.1111/mmi.15267 · Cited by 14
Metadata
- Authors
- Wistrom, J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-01
- Volume
- 47
- Issue
- 1
- Pages
- 43-50
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2097867359
- Cited by
- 448
- References
- 24
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.